SUBLESIONAL BONE LOSS SECONDARY TO SCI

Clinical trials for SUBLESIONAL BONE LOSS SECONDARY TO SCI explained in plain language.

Never miss a new study

Get alerted when new SUBLESIONAL BONE LOSS SECONDARY TO SCI trials appear

Sign up with your email to follow new studies for SUBLESIONAL BONE LOSS SECONDARY TO SCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Bone-Building drug combo shows promise for spinal cord injury patients

Disease control Ongoing

This study tests whether a two-step drug treatment can improve bone density in people with chronic spinal cord injury (SCI) who have bone loss below the injury level. Participants receive either romosozumab (a bone-building drug) or a placebo for 12 months, followed by denosumab …

Matched conditions: SUBLESIONAL BONE LOSS SECONDARY TO SCI

Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control

Last updated Jun 11, 2026 12:09 UTC

SUBLESIONAL BONE LOSS SECONDARY TO SCI

Get alerted when new SUBLESIONAL BONE LOSS SECONDARY TO SCI trials appear

Bone-Building drug combo shows promise for spinal cord injury patients